tiprankstipranks
Cadrenal Therapeutics, Inc. (CVKD)
NASDAQ:CVKD
US Market
Holding CVKD?
Track your performance easily

Cadrenal Therapeutics, Inc. (CVKD) Financial Statements

237 Followers

Cadrenal Therapeutics, Inc. Financial Overview

Cadrenal Therapeutics, Inc.'s market cap is currently ―. The company's EPS TTM is $-7.299; its P/E ratio is -2.25; Cadrenal Therapeutics, Inc. is scheduled to report earnings on March 17, 2025, and the estimated EPS forecast is $-2.02. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue-----
Gross Profit----$ -220.09K
EBIT$ -2.41M$ -2.39M$ 1.66M$ -1.14M$ -1.04M
EBITDA$ -2.41M$ -2.39M$ 1.66M$ -1.14M$ -1.04M
Net Income Common Stockholders$ -2.41M$ -2.39M$ -1.66M$ -7.32M$ 5.14M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 0.00$ 0.00$ 6.57M$ 8.40M$ 9.11M
Total Assets$ 4.68M$ 5.46M$ 7.05M$ 8.52M$ 9.31M
Total Debt$ 2.23K$ 8.80K$ 15.17K$ 21.35K$ 27.22K
Net Debt$ 2.23K$ 8.80K$ -6.55M$ -8.38M$ -9.08M
Total Liabilities$ 1.27M$ 1.46M$ 856.32K$ 826.88K$ 565.80K
Stockholders Equity$ 3.41M$ 3.99M$ 6.19M$ 7.69M$ 8.75M
Cash Flow-
Free Cash Flow$ -2.20M$ -1.53M$ -1.84M$ -694.45K$ -627.78K
Operating Cash Flow$ -2.20M$ -1.53M$ -1.84M$ -694.45K$ -627.78K
Investing Cash Flow----$ -1.00
Financing Cash Flow$ 1.53M-$ 298.00$ -12.50K$ 6.51M
Currency in USD

Cadrenal Therapeutics, Inc. Earnings and Revenue History

Cadrenal Therapeutics, Inc. Debt to Assets

Cadrenal Therapeutics, Inc. Cash Flow

Cadrenal Therapeutics, Inc. Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis